Krypton (Cannabis flos Canopy Growth): myrcene in the profile and two entries under one name

• Who supplies it. Exclusively Canopy Growth, so there is nothing to compare versions with, and a supply break means the absence of this strain, not another version of it.
• Profile. It leads with myrcene, alongside humulene, caryophyllene, limonene, linalool. We do not provide percentage shares because sources count them against different totals.
• Origin. Established lineage, parents are Chemdawg 91 and Captain Krypt Og.
• What is missing. Two sources describe the profile differently, so the further part of the set is disputed, not established.

What is this strain and where does it come from?

Krypton is a strain with a documented lineage: the parents are recorded as Chemdawg 91 and Captain Krypt Og. The genetic base is cataloged under the name 91 Krypt, attributed to the breeder DNA Genetics, and the raw material reaches Polish pharmacies from Canada, under the Spectrum Therapeutics brand owned by Canopy Growth.

The 91 component in the name refers to the numbered selection of the Chemdawg family, separated by American breeders into distinct lines. The second parent, Captain Krypt Og, comes from the OG family. Both entries come from breeding catalogs and the description of the entity that commercialized this genetics, not from genetic testing, so they speak of the breeder’s declaration, not the confirmed identity of the plant. For some entries in this set, such a declaration is not present at all, and then we write about an unknown lineage; here it is different.

The trade name does not prove kinship in any direction. This is evident in Electric Honeydew, whose lineage states 91 og krypt melon: a common word does not make it a sibling of this strain, as it comes from a different catalog and describes a different entry. It also happens the other way around, when two entries without a single common word in the name have a documented common parent.

The classification itself can be recorded inconsistently: one database describes Krypton as an indica, the other as a hybrid. There is no resolution because neither provides the basis for that assignment.

Which producers supply this strain to Polish pharmacies?

One. Krypton is supplied exclusively by Canopy Growth, a Canadian producer selling medical raw material under the Spectrum Therapeutics brand. However, in Polish listings, this name appears in two separate entries conducted under the same registration name, and it is these, not two producers, that create the impression of two pharmacy versions.

The registration name combines the term Cannabis flos with the producer’s name and declared content. We omit the numerical component of this name because it is a value declared by the producer, and in this entry, no available source provides the deviation it is allowed to have. Quoted without this reservation, it would appear to be the result of testing a specific batch, which it is not.

Both rows indicate the same entity and the same registration name, so from the prescription point of view, it is one entry. Databases still lead them separately and assign them different descriptions. This reflects the state of entries in sources, not the established identity of two strains: this cannot be resolved without a certificate of analysis for a specific batch, which neither database publishes.

What can actually be purchased changes faster than the names themselves. One halted wholesale order or the end of a permit can remove an entry from the shelf for months, and with one producer, there is nothing to replace it within the same name. We conduct a current review in the list of strains available in Polish pharmacies. Other entries from the same producer are described in the text about Canopy Growth.

The raw material dispensed from the pharmacy on prescription is different from the hemp flower sold over the counter, categorized in the store as a separate category. Both are allowed on different legal bases, so the description of one cannot be transferred to the other.

What does this strain smell and taste like?

• humulene humulene
• caryophyllene caryophyllene
• limonene limonene
• linalool linalool
• myrcene myrcene (leading in the pharmacy list)

Depending on which entry is read. One source describes the aroma as floral with a hint of pepper, the other as diesel, musky, and earthy. The common denominator of both descriptions is myrcene, a terpene associated with the smell of damp earth and overripe fruit. The taste follows the aroma and is often described similarly.

Sources differ in profile composition. One lists five terpenes for this name: myrcene, caryophyllene, limonene, linalool, and humulene. The other only lists myrcene as the leading position and ends the description there. Thus, four names stand only in one entry and cannot be confirmed, and in the second entry of the same registration name, the list can be even shorter.

We do not provide percentage shares for these names because it is unclear what they are counted against. For the same entries, summed values from Polish databases sometimes do not even reach half, and sometimes exceed four-fifths; in one of the entries for Krypton, the sum exceeds one hundred. A number without a known denominator reads in the text about the drug as a measurement result, which it is not.

Aroma descriptions follow this divergence. The entry with the shorter list of terpenes speaks of a heavy, diesel-earthy smell, while the entry with the longer list describes a floral scent with a sharp peppery accent, which is usually associated with caryophyllene. What is known about caryophyllene, limonene, linalool, and humulene is developed in separate texts. How to read such a profile is explained in the guide to strain profiles.

How long does it take for the strain to take effect and how long does the effect last?

There is no separate answer for Krypton. The course is determined by the route of administration, not the name on the label: after vaporization, it counts in minutes, after ingestion, in tens of minutes. For this cultivar, no one has measured the curve separately, so the ranges below speak of the method of intake, not the cultivar.

The route of administration determines the course more than the strain itself, and the ranges below describe it, not this cultivar, because pharmacokinetic studies for a single cultivar have not been published.

Lineage or terpene profile does not change anything here. None of the available sources provides a measurement of the duration of action for this name, and the two entries conducted under it differ in description, not physiology. What matters is the form in which the raw material comes from the pharmacy, and whether the patient vaporizes it or prepares an oral preparation from it.

What is known and what is not known about the effects of this strain?

For Krypton itself, nothing is known beyond what the commercial descriptions provide. There is no clinical study conducted on this strain. However, there are several works on the terpene, which databases place first in this profile, and these set the limit of what can be said here.

In humans, it has not been shown that myrcene alone alleviates insomnia at doses typical for inhalation of flower. The direction of the effect in rodents depends on the route of administration and the sex: after intraperitoneal injection in 2002, a slightly anxiogenic effect was described, and after inhalation in 2024, an anxiolytic effect in females. These two results do not cancel each other out; they only show that the conclusion depends on conditions, which no popular strain database provides.

The rest of what can be read about this strain is sales descriptions or patient reports. The term “relaxing,” which both databases assign to both entries, comes from their own descriptive category, not from measurement or study. What is known about myrcene itself is developed in a separate text.

What side effects have been reported from this strain?

None. The strain name is not a unit for which reports are collected, and with this entry, there is one more thing: two entries from databases go under the common registration name, so even if someone reported a symptom, they would have no way to assign it to one of them. Below is a description for the entire group of raw materials.

Reports of side effects are collected for a medicinal product with a batch number, not for a strain name, so the following pertains to hemp flower as a group of raw materials. The most commonly reported symptoms are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and transient worsening of short-term memory, as well as anxiety increasing with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not the description of the plant. We do not provide the frequency of these symptoms numerically because public listings for hemp flower in Poland do not separate them by individual products.

Additionally, there is the mode of dispensing. The raw material is a category Rpw medicine, and the decision about its use and combination with other preparations is made by the attending physician. A symptom that appears after changing strains may be the result of a different batch or a different method of intake, not the plant itself.

How to vaporize this strain?

Just like any other flower, because the setting pertains to the device, not the strain. The terpenes in the Krypton profile have different boiling points and do not evaporate at once: myrcene boils the lowest of the five, and for humulene, there is no atmospheric measurement at all. No source provides a recommended setting for this name.

Inhalation is the only route for which myrcene has been studied in a way somewhat similar to inhaling vapor from flower. Wagner and colleagues described in 2024 in NeuroSci (PMID:39728677) a simple model of such administration. With short inhalations mimicking inhalation administration in humans, beta-myrcene acted anxiolytically in the elevated plus maze in female mice, and in males only with a single inhalation. Unlike linalool, myrcene did not produce a synergistic effect with cannabidiol in either sex. No number from the mouse study translates to humans.

The boiling point is not a threshold below which the terpene does not evaporate, and the number set on the device is not the temperature of the flower in the chamber. Both matters are described separately because they pertain to every strain the same: evaporation of terpenes and the difference between setting and material. Comparing both entries of this name is not possible either, as analysis certificates broken down by terpenes are not published by the databases.

Which strains are related to it?

None of those that reach Polish pharmacies today. The pedigree chart in this set does not link Krypton to another entry: both of its parents appear in it only once, and the Chemdawg 91 line is not the same entry as Chemdawg itself, despite the common word.

Two strains in the set have Chemdawg in their lineage without a number: GMO and Tilray Sirius. This is the name of the entire family, not an identified single selection, so a common parent of this kind does not create siblings. If it were counted that way, half of American hybrids would be siblings, and such information would carry no weight.

A separate trap is Electric Honeydew, whose lineage states 91 og krypt melon. A common component of the name is not proof: it is an entry from a different catalog, and no one has shown that it describes the same plant.

An empty list of relationships with a known lineage is a result, not a gap to fill. Adding siblings by intuition creates false connections between entries, and these then circulate as facts. If any of the pharmacy entries receives a documented common parent, the entry about it will stand here.

Frequently Asked Questions about the Krypton strain

Are Krypton and Snowtorious Krypton the same strain?

It is unknown. Strain databases maintain both entries separately, indicating the same producer and the same registration name, but assigning them different terpene compositions and different aroma descriptions. This is the state of entries in sources, not the established identity of two strains.

Which terpene leads in the Krypton profile?

Myrcene. Both databases place it first, with one listing four other entries alongside it, while the other stops at myrcene alone. We do not provide percentage shares because sources count them against different denominators.

How many producers supply Krypton to Polish pharmacies?

One, Canopy Growth, selling under the Spectrum Therapeutics brand. With one producer, a supply break has no replacement within the same name, so doctors usually write on the prescription for raw material with a similar profile.

Does myrcene induce sleep?

In humans, this has not been shown. Studies on mice yielded results dependent on the route of administration and the sex of the animals, and the doses used do not translate to the amount inhaled from flower.

What is the lineage of Krypton?

The parents are recorded as Chemdawg 91 and Captain Krypt Og, and the genetic base is cataloged under the name 91 Krypt. These are breeding records, not the result of genetic testing.

Why do we not provide THC content for this strain?

Because sources provide only the declared value for this entry, without the deviation it is allowed to have. Taken out of this context, it would appear to be the result of testing a batch, which it is not.

Hemp flower is a pharmaceutical raw material dispensed on a doctor’s prescription in the Rpw category. The material is informational in nature, does not replace medical advice, and is not an encouragement to use.

Editorial text: editorial team ubucha.pl.